US Stock MarketDetailed Quotes
ADCT ADC Therapeutics
- 1.910
- -0.220-10.33%
Close Dec 18 16:00 ET
184.68MMarket Cap-0.80P/E (TTM)
2.210High1.900Low948.29KVolume2.140Open2.130Pre Close1.92MTurnover1.23%Turnover RatioLossP/E (Static)96.69MShares6.04052wk High-1.07P/B146.75MFloat Cap1.45052wk Low--Dividend TTM76.83MShs Float56.590Historical High--Div YieldTTM14.55%Amplitude0.360Historical Low2.022Avg Price1Lot Size
About ADC Therapeutics Company
ADC Therapeutics SA is a clinical-stage biotechnology company. It engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Company Profile
SymbolADCT
Company NameADC Therapeutics
Listing DateMay 15, 2020
Issue Price19.00
Founded2011
CEOMr. Ameet Mallik
MarketNYSE
Employees274
Fiscal Year Ends12-31
AddressBiop?le,Route de la Corniche 3B
CityEpalinges
ProvinceVaud
CountrySwitzerland
Zip Code1066
Phone41-212-653-02-00
Company Executives
- Name
- Position
- Salary
- Ameet Mallik
- Chief Executive Officer and Director
- 3.78M
- Peter J. Graham
- Chief Legal Officer
- --
- Mohamed Zaki, M.D.,PhD
- Chief Medical Officer
- 4.40M
- Jose Carmona
- Chief Financial Officer
- 1.26M
- Lisa Michelle Kallebo
- Corporate Controller and Chief Accounting Officer
- --
- Ron Squarer
- Chairman of the Board
- 526.73K
- Thomas Pfisterer
- Director
- 194.30K
- Dr. Tyrell J. Rivers, PhD
- Independent Director
- --
- Viviane Monges
- Independent Director
- 231.33K
- Peter Hug, PhD
- Lead Independent Director
- 212.61K
- Dr. Victor Sandor, C.M.,M.D.
- Independent Director
- 227.72K
- Robert W. Azelby
- Independent Director
- 127.67K
- Dr. Jean-Pierre Bizzari, M.D.
- Independent Director
- 197.81K
Heat List
US
Overall
Symbol
Price
% Chg
No Data